Rare forms of dementia: Final Report



Similar documents
Alzheimer s and other related diseases: coping with behavioural disorders in the patient s home

UPDATES TO NEUROCOGNITIVE DISORDERS IN DSM-5 and DSM-5 DESK REFERENCE UPDATED

Intellectual Symptoms Amnesia: Loss of memory function

Objectives. Aging and Forgetfulness Define Dementia Types of Dementia Treatment

Social Security Disability Insurance and young onset dementia: A guide for employers and employees

«How can patient organisations trigger a EU funded rare disease project»

Alzheimer s Australia Submission on the Draft Report of the Productivity Commission Inquiry into Disability Care and Support

Sandro Sorbi DIPARTIMENTO DI SCIENZE NEUROLOGICHE E PSICHIATRICHE

No. prev. doc.: 8770/08 SAN 64 Subject: EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS COUNCIL MEETING ON 9 AND 10 JUNE 2008

THE ROLE OF PUBLIC SUPPORT IN THE COMMERCIALISATION OF INNOVATIONS

Diagnosis and Initial Management of Cognitive Disorders

10TH EDITION MERGER CONTROL VADEMECUM FILING THRESHOLDS AND CLEARANCE CONDITIONS IN THE 29 EUROPEAN JURISDICTIONS

Replacement Migration

EU Lesson Plan. Name of Teacher: Sharon Goralewski School: Oakland Schools Title of Lesson Plan: The European Union: United in Diversity

Measles and rubella monitoring

MOBILISING THE POTENTIAL OF ACTIVE AGEING IN EUROPE Trends in Healthy Life Expectancy and Health Indicators Among Older People in 27 EU Countries

THE ORGANISATION AND FINANCING OF HEALTH CARE SYSTEM IN LATVIA

(Resolutions, recommendations and opinions) RECOMMENDATIONS COUNCIL

Mental health issues in the elderly. January 28th 2008 Presented by Éric R. Thériault

COMMISSION OF THE EUROPEAN COMMUNITIES

COPYRIGHT Danish Standards. NOT FOR COMMERCIAL USE OR REPRODUCTION. DS/EN :2000

Health Care Systems: Efficiency and Policy Settings

hepatolenticular degeneration (E83.0) human immunodeficiency virus [HIV] disease (B20) hypercalcemia (E83.52) hypothyroidism, acquired (E00-E03.

The Private Health Insurance Market in Europe

1: Motor neurone disease (MND)

Solvency II and key considerations for asset managers

2016 Programs & Information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

Cognitive Testing for Underwriting Life Insurance

Metallic products Types of inspection documents

Electronic Health Record Systems and Secondary Data Use

Draft guidelines and measures to improve ICT procurement. Survey results

Information for applicants, employers and supervisors. Periods of adaptation

COUNCIL OF THE EUROPEAN UNION. Brussels, 7 October 2003 (OR. en) 12858/03 RECH 152 OC 589

SWECARE FOUNDATION. Uniting the Swedish health care sector for increased international competitiveness

Michael E Dewey 1 and Martin J Prince 1. Lund, September Retirement and depression. Michael E Dewey. Outline. Introduction.

Global Economic Impact of Multiple Sclerosis

PRIORITY RULES ON COMPENSATION FOR NUCLEAR DAMAGE IN NATIONAL LEGISLATION

Parking card for people with disabilities in the European Union:

The Hague Convention of 13 January 2000 on the International Protection of Adults

COPYRIGHT Danish Standards. NOT FOR COMMERCIAL USE OR REPRODUCTION

Waiting times and other barriers to health care access

SIXTY-SEVENTH WORLD HEALTH ASSEMBLY. Agenda item May Hepatitis

Lewy body dementia Referral for a Diagnosis

CE Marking: Your Key to Entering the European Market

Cholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW

ING International Survey. Strong demand across Europe for financial education in schools

ACCESSIBLE INFORMATION PROVISION FOR LIFELONG LEARNING KEY POLICY MESSAGES

INTERNATIONAL COMPARISONS OF PART-TIME WORK

Beer statistics edition. The Brewers of Europe

Diagnostic Decision Support by Intelligent Medical Image Retrieval with Electronic Medical Record for Dementia Treatment Enhancement

Newborn Screening Issues

J/601/2874. This unit must be assessed in accordance with Skills for Care and Development s QCF Assessment Principles.

COOPERATION AGREEMENT ON A CIVIL GLOBAL NAVIGATION SATELLITE SYSTEM (GNSS) BETWEEN THE EUROPEAN COMMUNITY AND ITS MEMBER STATES AND UKRAINE

INNOBAROMETER THE INNOVATION TRENDS AT EU ENTERPRISES

Progress The EU programme for employment and social solidarity

EU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE

Alzheimer s disease. What is Alzheimer s disease?

Fluoride and Dental Health in Europe

Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment

AGREEMENT REGARDING THE EXECUTIVE BOARD OF RAIL FREIGHT CORRIDOR RHINE-ALPINE

Data Centre Pricing in Europe 2013 to 2018

10. European Union. (a) Past trends

MEASUREMENT OF FLUID FLOW BY MEANS OF PRESSURE DIFFERENTIAL DEVICES INSERTED IN CIRCULAR CROSS-SECTION CONDUITS RUNNING FULL - PART 1:

Roche Position on Human Stem Cells

Magnetic Resonance Techniques in Neurodegenerative Diseases First Course Alzheimer s disease and frontotemporal lobar degeneration spectrum

Executive Summary Study on Co-Regulation Measures in the Media Sector

The structure of the European education systems. schematic diagrams. Eurydice Highlights. Education and Training

Early Childhood Education and Care

Primary Endpoints in Alzheimer s Dementia

The structure of the European education systems 2012/13: schematic diagrams

Patients with dementia and other types of structural brain injury are predisposed to delirium (i.e., abrupt onset, temporary confusion caused by

ALCOHOL RELATED DISORDERS Includes Alcohol Abuse and Alcohol Dependence; Does Not Include Alcohol Use Disorders

The State of Oral Health in Europe. Professor Kenneth Eaton Chair of the Platform for Better Oral Health in Europe

Delegation in human resource management

Alzheimer s and. memory loss

What is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician

No. 1 Choice for Europe s Leading Brands e-recruitment

SUPPLEMENTARY PROTECTION CERTIFICATES FOR MEDICINAL PRODUCTS

ACP-NEP Co-ord (Smith, Lyn C2) Military Goods: A400M Collaborative Programme OPEN GENERAL EXPORT LICENCE APRIL 2014

ÖNORM EN Valve proving systems for automatic shut-off valves for gas burners and gas appliances

Association of the Councils of State and Supreme Administrative Jurisdictions of the EU

CO 2 -based Motor Vehicle Tax

The ICD-9-CM uses an indented format for ease in reference I10 I10 I10 I10. All information subject to change

FASTENERS - ACCEPTANCE INSPECTION (ISO 3269:2000) IRISH STANDARD I.S. EN ISO 3269:2000. Price Code. Údarás um Chaighdeáin Náisiúnta na héireann

The European Commission s strategy on Corporate Social Responsibility (CSR) : achievements, shortcomings and future challenges

Access to Health Care for Migrants, Ethnic Minorities, and Asylum Seekers in Europe

Transcription:

Rare forms of dementia: This project has received financial support from the European Commission. Neither the European Commission nor any person acting on its behalf is responsible for any use that might be made of the following information.. Alzheimer Europe. Route de Thionville 145. L- 2611 Luxembourg.

Table of contents 1. INTRODUCTION...4 2. EXPERT GROUP...5 3. EXPERTS MEETINGS...5 4. COLLECTION OF EXISTING INFORMATION...6 4.1. LISTS OF DOCUMENTS COLLECTED FROM MEMBER ORGANISATION OF ALZHEIMER EUROPE...6 4.2. INFORMATION OBTAINED ON INTERNET...7 5. RARE FORMS OF DEMENTIA...8 6. CLASSIFICATION SYSTEMS...10 7. FRAMEWORK OF THE DATABASE OF INFORMATION...11 7.1. GENERAL INTRODUCTION...11 7.2. DESCRIPTIVE CATEGORIES...12 8. FINAL DOCUMENT...13-3 -

1. Introduction The number of people suffering from rare forms of dementia is by definition low and consequently very little has been done to provide information in the same way that it has been for other more common forms such as Alzheimer s disease. However, when one adds up the number of people in the whole of Europe suffering from a rare form of dementia, there is a sizeable group of people who would benefit from information i.e. on the characteristics of a particular form of dementia, its progression, its treatment possibilities, the problems caregivers face, its prevention The aim of this project was to build up a database of information about rare forms of dementia and to make this available to the general public by means of the existing Internet and Intranet systems of Alzheimer Europe. The project would enable quality information on rare forms of dementia to be disseminated throughout Europe. The description of the diseases was carried out by a group of professionals in order to ensure that the information used was correct and up-to-date. However, it was of primary importance to ensure that the information was written and presented in a style, which was accessible and understandable by the general public. The working methodology of this project was: To elaborate a list of rare forms of dementia To group these rare diseases in a classification system To define the framework of the future database To collect quality information To analyse the existing information To present the information on rare forms of dementia in an easy-tounderstand fashion To elaborate a glossary to explain specific words To build up the Rare Forms of Dementia Database To insert this collected information into the database - 4 -

2. Expert group Alzheimer Europe created an expert group made up of different member organisations of Alzheimer Europe and professionals. This group was established in order to ensure that the information used was correct and up-to-date as well as to ensure that the information database was widely circulated in the different member States of the European Union. Hereafter you will find the list of persons involved in this expert group. For full details, please see Annex 1. Kurt Jellinger (Austria) André Delacourte (France) Alexander Kurz (Germany) Giuliano Binetti (Italy) Jos Van der Poel (The Netherlands) Clive Evers (United Kingdom) Unfortunately, Gunhild Waldemar (Rikshospitalet, Copenhagen) was unable to participate in the project. But luckily Giuliano Binetti, a neurologist working for the Alzheimer Unit at Brescia (Italy), agreed to be a part of the expert group. 3. Experts meetings The first expert group meeting was held in Luxembourg on 17-19 January 2003. During this meeting, the experts had to agree on the establishment of a general structure for the database of information about rare forms of dementia: to elaborate a list of rare diseases, to classify these diseases, to elaborate relevant categories of information and to collect quality information. A second meeting was organised in Luxembourg on 17-18 May 2003. It was mainly dedicated to the analysis of the descriptions of the diseases and to improve the classification system and the descriptive categories (Please see Annex 2 for the agenda and the minutes of the two meetings). - 5 -

4. Collection of existing information 4.1. Lists of documents collected from member organisation of Alzheimer Europe First we analysed certain publications of our member organisations. Some countries had information relevant to the project, whereas others had none. In general, there was very little written material available on this subject. Hereafter you will find the list of the existing documents. Country Association Brochures Language Finland Alzheimer-keskusliitto Vaskulaarinen dementia Finnish Finland Alzheimer-keskusliitto Lewyn kappale-tauti Finnish Finland Alzheimer-keskusliitto Frontaalinen eli otsalohkodementia Finnish Sweden Demensförbundet Vad är demen? Swedish Sweden Demensförbundet Demens-sjukdomen Swedish Sweden Demensförbundet Rättighets fonden Swedish The Netherlands Alzheimer Nerderland Lewy body dementie Dutch The Netherlands Alzheimer Nerderland Vasculaire dementie Dutch The Netherlands Alzheimer Nerderland Ziekte van Pick Dutch United Kingdom Alzheimer s Disease Creutzfeldt-Jakob Disease English Society Country Association Articles Language Sweden Demensförbundet Doktorn har ordet Frontallobsdemens Swedish Article extract from Demens-Forum NR4-2002 Sweden Demensförbundet Tröst till personer med svar demens Swedish Article extract from Demens-Forum NR1-2003 Switzerland Association Alzheimer Suisse L évolution d une paralysie supranucléaire progressive French, German Article extract from Alzheimer Info 29 Switzerland Association Alzheimer Suisse L évolution d une aphasie progressive primaire Article extract from Alzheimer Info 30 French, German Switzerland Association Alzheimer Suisse L évolution d une démence avec corps de Lewy Article extract from Alzheimer Info 31 French, German Switzerland Association Alzheimer Suisse Maladie de Creutzfeldt-Jakob Article extract from Alzheimer Info 32 French, German - 6 -

Country Association Information sheets Language The Netherlands Alzheimer Nerderland De ziekte van Creutzfeld-jakob Dutch The Netherlands Alzheimer Nerderland Lewy body ziekte Dutch The Netherlands Alzheimer Nerderland Ziekte van Parkinson en dementie Dutch The Netherlands Alzheimer Nerderland Ziekte van Pick Dutch The Netherlands Alzheimer Nerderland Vasculaire dementie Dutch The Netherlands Alzheimer Nerderland Het Korsakov syndroom Dutch United kingdom Alzheimer Scotland - Dementia with Lewy bodies English Action on Dementia United Kingdom Alzheimer Scotland - Vascular dementia English Action on Dementia United Kingdom Alzheimer s Disease Dementia with Lewy bodies English Society United Kingdom Alzheimer s Disease What is Korsakoff s syndrome? English Society United Kingdom Alzheimer s Disease Society Rare causes of dementia English 4.2. Information obtained on Internet We had also established an inventory of existing information on rare forms of dementia available on the Internet and extensive material was obtained from this source. However it is important to stress that the majority of this available information was written in a medical language and not adapted to the general public. (Please see Annex 3 for a list of material obtained). - 7 -

5. Rare forms of dementia According to the programme of community action on rare diseases: "For the purposes of this programme, rare diseases, including those of genetic origin, are life-threatening or chronically debilitating diseases which are of such low prevalence that special combined efforts are needed to address them so as to prevent significant morbidity or perinatal or early mortality or a considerable reduction in an individual's quality of life or socio-economic potential; As a guide, low prevalence can be understood as meaning prevalence which is generally recognised as less than 5 per 10 000 in the Community." On the basis of the general epidemiological data available, people who have dementia account for more or less 1% of the global population in the European community 1. It is generally accepted that the majority of dementias are caused by Alzheimer s disease (approximately 50%) and Vascular Dementias (approximately 25%). For this reason, these common dementias were not covered in this project. However the expert group decided to add a section on the rare variants of the common causes of dementias. The expert group also decided to limit the rare diseases to forms of dementia occurring in adults (the ones appearing in infants and children will be not covered in this project). 1 Hofman, A. et al. (1991), The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings, International Journal of Epidemiology, Volume 20, No.3, pages 736-748. - 8 -

People having Epidemiological data Dementia in general 100/10.000 Alzheimer s disease (AD) (+/- 50% of the global population having dementia) Vascular dementias (VD) (+/- 25% of the global population having dementia) Fronto-temporal degeneration (FTD) including Pick s disease, Primary Progressive Aphasia, (+/- 6,25% of the global population having dementia) Lewy Body Diseases (LBD) including Lewy Body Dementia and dementia in Parkinson s disease (+/- 6,25% of the global population having dementia) 50/10.000 25/10.000 6,25/10.000 6,25/10.000 Dementia in the global population AD VD FTD LBD The rest - 9 -

6. Classification systems Working from the epidemiological data agreed upon, the group of experts established a classification system during the first meeting for the rare forms of dementia. In order to improve the classification system, the expert group decided to add a new sub-category called Cerebro-vascular diseases. This category will cover rare forms of vascular dementias such as CADASIL, Binswanger disease, Amyloid angiopathy and Subdural hematoma. Other rare forms of dementia were also included in this classification system. Hereafter you will find the list of the different diseases included in the Classification system. Name Category Person in charge 1. Familial British Dementia Degenerative André Delacourte 2. Postencephalitic Parkinsonism Infectious Kurt Jellinger 3. Hallervorden-Spatz Metabolic Kurt Jellinger 4. Herpes Encephalitis Infectious Kurt Jellinger 5. Dementia in hepatic and renal failure Metabolic Kurt Jellinger 6. Subdural hematoma Cerebro-vascular Kurt Jellinger 7. Dementia in chronic intoxications Toxic Kurt Jellinger 8. Drug induced dementia Toxic Kurt Jellinger 9. Chronic hypovitaminoses Metabolic Kurt Jellinger 10. Down syndrome Degenerative Jos Van der Poel 11. GSS and FFI Infectious André Delacourte During the second meeting, other changes were also suggested by the expert group such as: To include Familial Autosomal Dominant AD under Degenerative disease as N 1 To rename the category entitled Other rare diseases causing dementia by Other rare causes of dementia To rename Lewy Body Spectrum by Lewy Body Disease To rename Fronto-temporal dementia by Fronto-temporal degeneration For the full reviewed Classification system, please see Annex 4. - 10 -

7. Framework of the database of information 7.1. General Introduction In order to improve the understanding of the rare forms of dementia, the expert group decided to elaborate a General Introduction. The objective of this introduction was mainly to assemble basic information common to all the rare forms of dementia analysed within the framework of our project. The general introduction is made up of 5 specific sections presenting general information on: 1. Dementia : definition and concept 2. The functioning of the brain 3. The diagnostic procedures 4. Genetic causes of dementia 5. Care and treatment of dementia including the patient perspectives, the caregiver problems, the financial aspects, the legal aspects, the drug treatment and nondrug treatment. The expert group agreed on the importance that the information should be written and presented in a style that will ensure that it is accessible and understandable by the general public. - 11 -

7.2. Descriptive categories In order to have comparative information, the experts stressed the importance that all the rare forms of dementia should be described under the same descriptive categories. However, these categories were directly linked to the needs of the target audience. The target audience consisted of a variety of people such as caregivers, family members, family associations, patients and general practitioners. The needs of information were different from one group to another. According to the differences, the experts decided to elaborate two major sections: For the caregivers, family members, family associations and patients, the information is supposed: To improve the understanding of other forms of dementia than Alzheimer s disease To help family members and caregivers to better understand the patient To reduce caregivers burden and family conflicts To improve the quality of care For the general practitioners, the information is supposed: To facilitate identification of non-alzheimer and non-vascular dementias To improve the differential diagnosis To ensure the identification of treatable causes To avoid ineffective and expensive treatment On the basis of this analysis, descriptive categories were proposed during the first meeting and reviewed during the second meeting. In order to avoid oversimplifying too much the diseases information, the experts decided to elaborate a glossary that will explain the more technical words. - 12 -

Hereafter you will find the final descriptive categories. 1. General outline (Ensure that dementia/cognitive impairment are included) 2. Synonyms 3. Symptoms and Course Caregiver problems (only if these are specific) 4. Causes and risk factors 5. Genetics 6. Diagnostic procedures 7. Care and treatment 8. Frequency 9. Ongoing research / Clinical trials 10. Available services 11. References 8. Final document All the information on the rare forms of dementia and the general introduction are now available on Alzheimer Europe Internet site under the section Other forms of dementia. Here is the URL address to consult this available information: http://www.alzheimer-europe.org/?lm1=d76ebf7f6aea The advantages of the Internet tool are that detailed information can be accessible world wide and constantly updated. The Alzheimer Europe Internet site gives also the opportunity to the users to print an article on specific diseases without banners or to email it to a friend. The glossary is also consultable on Alzheimer Europe Internet site by clicking on View Glossary button and let the opportunity to the user to find a specific word. This glossary is also directly linked to the articles presenting the diseases information and when a word is defined in the glossary, it will be highlighted in blue. When the user moves his/her cursor over a word, the definition will appear automatically in a pop-up window. Please see the final document, including the General Introduction, the description of all the diseases and the glossary herewith enclosed. - 13 -

Annex 1 : List of participants Annex 2 : Agenda and minutes of the 2 Experts meetings Annex 3 : Information obtained on Internet Annex 4 : Classification system - 14 -

This report was produced by a contractor for Health & Consumer Protection Directorate General and represents the views of the contractor or author. These views have not been adopted or in any way approved by the Commission and do not necessarily represent the view of the Commission or the Directorate General for Health and Consumer Protection. The European Commission does not guarantee the accuracy of the data included in this study, nor does it accept responsibility for any use made thereof.